These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3487288)

  • 1. Immunologic abnormalities in linear scleroderma.
    Vázquez F; Requena L; Cristobal P; Aguilar A; Sánchez de Paz F; Garcia-Pérez A
    Arch Dermatol; 1986 Jun; 122(6):623-4. PubMed ID: 3487288
    [No Abstract]   [Full Text] [Related]  

  • 2. Practice gaps: Evaluating the clinical utility of autoantibodies in morphea.
    Chiu YE
    JAMA Dermatol; 2013 Oct; 149(10):1166. PubMed ID: 23925297
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-single-stranded DNA antibody and muscle involvement in localized scleroderma.
    Takehara K; Kikuchi K; Soma Y; Igarashi A; Ishibashi Y
    Arch Dermatol; 1990 Oct; 126(10):1368. PubMed ID: 2221947
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence and characteristics of anti-single-stranded DNA antibodies in localized scleroderma. Comparison with systemic lupus erythematosus.
    Ruffatti A; Peserico A; Rondinone R; Calligaro A; Del Ross T; Ghirardello A; Germino M; Todesco S
    Arch Dermatol; 1991 Aug; 127(8):1180-3. PubMed ID: 1863075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High titers of antibodies to single-stranded DNA in linear scleroderma.
    Falanga V; Medsger TA; Reichlin M
    Arch Dermatol; 1985 Mar; 121(3):345-7. PubMed ID: 3883904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea.
    Falanga V; Medsger TA; Reichlin M
    Arch Dermatol; 1987 Mar; 123(3):350-3. PubMed ID: 3545090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CD4 and CD8 in serum from patients with localized scleroderma.
    Sato S; Fujimoto M; Kikuchi K; Ihn H; Tamaki K; Takehara K
    Arch Dermatol Res; 1996 Jun; 288(7):358-62. PubMed ID: 8818182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localized scleroderma is an autoimmune disorder.
    Takehara K; Sato S
    Rheumatology (Oxford); 2005 Mar; 44(3):274-9. PubMed ID: 15561734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antinuclear antibodies in a case of linear scleroderma with polyarthritis].
    Marquet R; Vilardell M; Villar M; de la Figuera M
    Med Clin (Barc); 1983 Nov; 81(15):693. PubMed ID: 6606745
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased levels of circulating intercellular adhesion molecule-1 in patients with localized scleroderma.
    Ihn H; Fujimoto M; Sato S; Kikuchi K; Igarashi A; Soma Y; Takehara K
    J Am Acad Dermatol; 1994 Oct; 31(4):591-5. PubMed ID: 7916356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiochemical demonstration of serum antibodies against double stranded DNA in progressive and circumscribed scleroderma].
    Meffert H; Falck P; Sönnichsen N
    Dermatol Wochenschr; 1975 Sep; 161(9):771-2. PubMed ID: 1081055
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-agalactosyl immunoglobulin G antibodies in localized scleroderma.
    Mimra Y; Ihn H; Jinnin M; Asano Y; Yamane K; Yazawa N; Tamaki K
    Int J Dermatol; 2005 Oct; 44(10):817-20. PubMed ID: 16207181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphea in adults and children cohort III: nested case-control study--the clinical significance of autoantibodies in morphea.
    Dharamsi JW; Victor S; Aguwa N; Ahn C; Arnett F; Mayes MD; Jacobe H
    JAMA Dermatol; 2013 Oct; 149(10):1159-65. PubMed ID: 23925398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter to the editor. Re: Specificity of anti-centromere antibodies for scleroderma.
    Roberts-Thomson P
    Rheumatol Int; 2007 Dec; 28(2):197-8. PubMed ID: 17564709
    [No Abstract]   [Full Text] [Related]  

  • 15. [Presence of the antinuclear antibodies and antibodies to Borrelia burgdorferi among patients with morphea en plaque, deep linear scleroderma and atrophoderma Pasini-Pierini].
    Wojas-Pelc A; Wielowieyska-Szybińska D; Kiełtyka A
    Przegl Lek; 2002; 59(11):898-902. PubMed ID: 12715718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of linear scleroderma and myasthenia gravis.
    Kim HS; Chun YS; Hann SK; Park WH
    J Dermatol; 2000 Jan; 27(1):31-4. PubMed ID: 10692822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinuclear antibodies in children with localized scleroderma.
    Rosenberg AM; Uziel Y; Krafchik BR; Hauta SA; Prokopchuk PA; Silverman ED; Laxer RM
    J Rheumatol; 1995 Dec; 22(12):2337-43. PubMed ID: 8835572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunologic changes in linear scleroderma in children. Apropos of 11 cases].
    Fontan I; Taïeb A; Guillet G; Rommel A; Fontan D; Maleville J
    Ann Dermatol Venereol; 1988; 115(2):135-41. PubMed ID: 3293512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities.
    Falanga V; Medsger TA; Reichlin M; Rodnan GP
    Ann Intern Med; 1986 Jun; 104(6):849-57. PubMed ID: 3486617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticentromere antibody in localized scleroderma.
    Ruffatti A; Peserico A; Glorioso S; Fiocco U; Rossi L; Gambari P; Todesco S
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 1):637-42. PubMed ID: 3534010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.